Advertisement

InFo Hämatologie + Onkologie

, Volume 22, Issue 11, pp 16–20 | Cite as

Schwerpunkt Pankreaskarzinom

Schnittbilddiagnostik beim duktalen Adenokarzinom des Pankreas

  • Fabian Lohöfer
  • Georgios Kaissis
  • Rickmer BrarenEmail author
Schwerpunkt
  • 7 Downloads

Die Schnittbildgebung ist für die Diagnostik, Therapieplanung und Verlaufskontrolle des Pankreaskarzinoms von entscheidender Bedeutung. Computer- und Magnetresonanztomografie sind dabei keine Alternativen, sondern Techniken die ergänzend einzusetzen sind. Lesen Sie in der folgenden Übersicht, wann welche Modalität zum Einsatz kommen sollte und worauf dabei zu achten ist.

Literatur

  1. 1.
    Al-Hawary MM et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology. 2014;146 (1):291-304.e1Google Scholar
  2. 2.
    Aung KL et al. Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res. 2018;24(6):1344–1354CrossRefGoogle Scholar
  3. 3.
  4. 4.
    Collisson EA et al. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16(4):207–20CrossRefGoogle Scholar
  5. 5.
    Conroy T et al. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 2018;379(25):2395–406CrossRefGoogle Scholar
  6. 6.
    Deeb A et al. Pulmonary metastases in pancreatic cancer, is there a survival influence? J Gastrointest Oncol. 2015;6(3):E48–51PubMedPubMedCentralGoogle Scholar
  7. 7.
    Feng L et al. Compressed sensing for body MRI. J Magn Reson Imaging. 2017;45(4):966–87CrossRefGoogle Scholar
  8. 8.
    George E et al. Dual energy CT applications in pancreatic pathologies. Br J Radiol. 2017;90(1080):20170411CrossRefGoogle Scholar
  9. 9.
  10. 10.
    Isaji S et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1):2–11CrossRefGoogle Scholar
  11. 11.
    Ito T et al. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology. 2017;17(3):451–6CrossRefGoogle Scholar
  12. 12.
    Jeon SK et al. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Eur Radiol. 2018;28(8):3484–93CrossRefGoogle Scholar
  13. 13.
    Kaissis G et al. A prospectively validated machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma. bioRxiv. 2019;  https://doi.org/10.1101/643809
  14. 14.
    Kaissis G et al. A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy. PLoS One. 2019;14(10):e0218642CrossRefGoogle Scholar
  15. 15.
    Kaissis GA et al. Borderline-resectable pancreatic adenocarcinoma: Contour irregularity of the venous confluence in pre-operative computed tomography predicts histopathological infiltration. PLoS One. 2019;14(1):e0208717CrossRefGoogle Scholar
  16. 16.
    Kindler HL et al. POLO: A randomized phase III trial of olaparib tablets in patients with metastatic pancreatic cancer (mPC) and a germline BRCA1/2mutation (gBRCAm) who have not progressed following first-line chemotherapy. J Clin Oncol. 2015;33(15_suppl):Abstr TPS4149CrossRefGoogle Scholar
  17. 17.
    Klauss M et al. Dual-energy perfusion-CT of pancreatic adenocarcinoma. Eur J Radiol. 2013;82(2):208–14CrossRefGoogle Scholar
  18. 18.
    Ko Y et al. Limited detection of small (≤ 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection. PLoS One. 2017;12(12):e0189797CrossRefGoogle Scholar
  19. 19.
    Ma C et al. High resolution diffusion weighted magnetic resonance imaging of the pancreas using reduced field of view single-shot echo-planar imaging at 3 T. Magn Reson Imaging. 2014;32(2):125–31CrossRefGoogle Scholar
  20. 20.
    Marion-Audibert AM et al. Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study. AJR Am J Roentgenol. 2018;211(5):W217–W225CrossRefGoogle Scholar
  21. 21.
    McMahon PM et al. Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectability. Radiology. 2001;221(1):93–106CrossRefGoogle Scholar
  22. 22.
    Michelakos T et al. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX. Ann Surg. 2019;269(4):733–40CrossRefGoogle Scholar
  23. 23.
    Nagayama Y et al. Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma. Eur Radiol. 2019;  https://doi.org/10.1007/s00330-019-06337-y
  24. 24.
    Nishiyama Y et al. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann Nucl Med. 2005;19(6):491–7CrossRefGoogle Scholar
  25. 25.
    Peng JS et al. Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer. Hepatobiliary Pancreat Dis Int. 2019;18(4):373–8CrossRefGoogle Scholar
  26. 26.
    Quiney B et al. Dual-energy CT increases reader confidence in the detection and diagnosis of hypoattenuating pancreatic lesions. Abdom Imaging. 2015;40(4):859–64CrossRefGoogle Scholar
  27. 27.
    Riffel P et al. Zoomed EPI-DWI of the pancreas using two-dimensional spatially-selective radiofrequency excitation pulses. PLoS One. 2014;9(3):e89468CrossRefGoogle Scholar
  28. 28.
    Riviere DM et al. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI. Abdom Radiol (NY). 2019;44(5):1756–65CrossRefGoogle Scholar
  29. 29.
    Sato M et al. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Ann Nucl Med. 2009;23(1):49–57CrossRefGoogle Scholar
  30. 30.
    Toft J et al. Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy. Eur J Radiol. 2017;92:17–23CrossRefGoogle Scholar
  31. 31.
    Versteijne E et al. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg. 2018;105(8):946–58CrossRefGoogle Scholar
  32. 32.
    Stewart BW, Wild CP (Hrsg.), International Agency for Research on Cancer. World Cancer Report 2014. Lyon: IARC Press; 2014Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Fabian Lohöfer
    • 1
  • Georgios Kaissis
    • 1
  • Rickmer Braren
    • 1
    • 2
    Email author
  1. 1.Radiologie, Klinikum rechts der Isar, Technische Universität MünchenMünchenDeutschland
  2. 2.Institut für diagnostische und interventionelle Radiologie, Fakultät für Medizin der Technischen Universität MünchenUniversitätsklinikum rechts der IsarMünchenDeutschland

Personalised recommendations